Latest Survival news
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
posted August 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study Offers Comprehensive Evaluation of Survival Parameters for Pediatric CNS Tumors
posted August 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cancer Diagnosis Not Tied to Later Healthier Eating Habits
posted July 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Estimated Glucose Disposal Rate Inversely Linked to Benign Prostatic Hyperplasia 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Small Change in Hours Benefits Emergency Physicians Working Night Shifts 
Safety Intervention Reduces Incidence of Postoperative Endophthalmitis Related Articles
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum 
Lung Transplant Can Prolong Survival in Stage IV NSCLC Monthly Specialist Briefings
Stay Connected
